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Abstract
Aging is associated with progressive loss of cardiovascular and skeletal muscle
function. The impairment in physical capacity with advancing age could be
related to an insufficient peripheral O2 delivery to the exercising muscles. Fur-
thermore, the mechanisms underlying an impaired blood flow regulation
remain unresolved. Cyclic guanosine monophosphate (cGMP) is one of the
main second messengers that mediate smooth muscle vasodilation and alter-
ations in cGMP signaling could, therefore, be one mechanism by which skele-
tal muscle perfusion is impaired with advancing age. The current study aimed
to evaluate the effect of inhibiting the main enzyme involved in cGMP degra-
dation, phosphodiesterase 5 (PDE5), on blood flow and O2 delivery in con-
tracting skeletal muscle of young and older humans. A group of young
(23  1 years) and a group of older (72  2 years) male human subjects per-
formed submaximal knee-extensor exercise in a control setting and following
intake of the highly selective PDE5 inhibitor sildenafil. Sildenafil increased leg
O2 delivery (6–9%) and leg O2 uptake (10–12%) at all three exercise intensi-
ties in older but not young subjects. The increase in leg O2 delivery with silde-
nafil in the older subjects correlated with the increase in leg O2 uptake
(r2 = 0.843). These findings suggest an insufficient O2 delivery to the contract-
ing skeletal muscle of aged individuals and that reduced cGMP availability is
a novel mechanism underlying impaired skeletal muscle perfusion with
advancing age.
Introduction
Life expectancy has steadily increased over the past two
centuries, resulting in an increasing number of older
individuals (Oeppen and Vaupel 2002). As aging is asso-
ciated with progressive loss of cardiovascular and skeletal
muscle function that often leads to progressive disability
(Doherty 2003) and increased risk of cardiovascular
disease (Buchner 2009), a better understanding of the
mechanisms that contribute to the age-related changes in
vascular and skeletal muscle function is needed.
Oxidative metabolism is the dominant source of energy
for skeletal muscle and to ensure sufficient availability of
O2, blood flow, and O2 delivery to the contracting mus-
cles are closely regulated to match the O2 demand
(Andersen and Saltin 1985; Saltin et al. 1998; Roach et al.
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1999; Gonzalez-Alonso et al. 2001). Aging has consistently
been reported to be associated with reduced blood flow
and O2 delivery to the exercising limb (Wahren et al.
1974; Proctor et al. 1998, 2003; Lawrenson et al. 2003;
Poole et al. 2003; Kirby et al. 2012; Nyberg et al. 2012)
but the mechanisms underlying the altered regulation of
exercise hyperemia have not been resolved (Proctor and
Parker 2006). Furthermore, to what extent a reduced
blood flow and O2 delivery to contracting skeletal mus-
cle of older individuals have metabolic and functional
consequences remain unclear (Proctor and Moore 2012).
Blood flow to skeletal muscle is determined by perfusion
pressure and vascular tone of which the latter is the
result of the balance between vasoconstrictor and
vasodilator signaling pathways in vascular smooth mus-
cle cells (VSMC). Among these regulatory mechanisms is
the cyclic nucleotide cyclic guanosine monophosphate
(cGMP), which mediates its effects via activation of
protein kinase G (PKG), is considered one of the main
second messengers that mediate vasodilation (Morgado
et al. 2012). Intracellular cGMP is degraded by cGMP-
binding phosphodiesterase 5 (PDE5), and concentrations
of cGMP are tightly controlled by this enzyme (Rybalkin
et al. 2003). Sildenafil has been shown to specifically
inhibit the catalytic site of PDE5 with a very high
selectivity for PDE5 and this compound can, therefore,
be used to potentiate cGMP signaling via inhibition of
cGMP degradation (Ballard et al. 1998; Corbin et al.
2003). This effect of sildenafil on cGMP signaling in the
vasculature can be assessed in vivo by infusion of the
endothelium-dependent vasodilator ACh and the nitric
oxide (NO) donor sodium nitroprusside (SNP) (en-
dothelium-independent vasodilator) as the vasoactive
effects of these compounds are mediated via formation
of cGMP (Hellsten et al. 2012).
Evidence in the literature indicates that cGMP signal-
ing may be impaired in aging. In older rats, the ability of
cGMP to stimulate PKG in VSMC has been shown to be
blunted compared to VSMC of young rats (Lin et al.
2001). Furthermore, the bioavailability of NO, which
mediates its vasodilator effect via production of cGMP, is
reduced in aging (Taddei et al. 2001; Nyberg et al. 2012).
To what extent alterations in cGMP signaling are
involved in the reduced blood flow and O2 delivery to
exercising skeletal muscle in aging humans remain
unknown.
We tested the hypothesis that potentiation of cGMP
signaling would increase blood flow, O2 delivery and O2
uptake in contracting skeletal muscle of older but not
young human subjects during submaximal exercise engag-
ing a small muscle mass. To accomplish this, we exam-
ined the effect of the highly selective PDE5 inhibitor
sildenafil on central and peripheral hemodynamics during
small muscle mass exercise in a group of young and older
subjects matched for physical activity level.
Methods
A total of 17 healthy male subjects of which 9 were young
(23  1 years) and 8 were older (72  2 years) partici-
pated in the study (Table 1). The subjects underwent
screening by means of a medical examination, 12-lead
electrocardiogram and blood sampling from the antecu-
bital vein. Exclusion criteria were history or symptoms of
cardiovascular disease, renal dysfunction, insulin resis-
tance, diabetes, or hypercholesterolemia. All subjects were
nonsmokers and none of the subjects were taking pre-
scription medicine. The study was approved by the Ethics
Committee of Copenhagen (H-3-2012-176) and con-
ducted in accordance with the guidelines of the Declara-
tion of Helsinki. Written informed consent was obtained
from all subjects before enrollment into the study.
Initial testing
Before the experimental day the subjects visited the labo-
ratory to become accustomed to the one-leg knee-
extensor model (Andersen and Saltin 1985) and to
perform an incremental bicycle ergometer exercise test in
which pulmonary maximal oxygen uptake (L min1,
Table 1. Subject characteristics.
Young Older
Age (years) 23  1 72  2*
Height (m) 1.83  0.01 1.80  0.02
Body weight (kg) 75.8  3.3 79.3  4.8
Body fat (%) 13.7  1.4 25.6  1.4*
Systolic blood pressure (mmHg) 117  3 138  5*
Diastolic blood pressure (mmHg) 60  1 62  3
Mean arterial blood pressure
(mmHg)
80  2 90  2*
VO2max (l/min) 3.42  0.24 2.42  0.12*
VO2max relative to body weight
(l/min/kg)
45.9  2.7 30.6  0.8*
Experimental leg mass (kg) 11.9  0.6 11.7  0.4
Experimental lean leg mass (kg) 10.0  0.5 8.9  0.2
Peak workload during knee-
extensor exercise (W)
48  3 37  2*
HbA1c (mmol/mol) 32  1 37  1*
Glucose, average (from HbA1c)
(mmol/l)
5.4  0.1 6.1  0.1*
Total cholesterol (mmol/l) 4.3  0.3 5.4  0.3*
HDL-C (mmol/l) 1.4  0.1 1.7  0.2
LDL-C (mmol/l) 2.6  0.2 3.2  0.2*
Values are means  SEM. Significant difference from young
*P < 0.05.
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_VO2max) was determined (Oxycon Pro, Intramedic, Gen-
tofte, Denmark; Table 1). An incremental test was also
performed in a one-leg knee-extensor ergometer to deter-
mine maximal workload (Wmax).
Experimental protocol
Subjects refrained from caffeine, alcohol, and exercise for
24 h before the experimental day. On the day of the
experiment the subjects arrived at the laboratory after eat-
ing breakfast. After local anesthesia (lidocaine,
20 mg mL1; Astra Zeneca, Copenhagen, Denmark),
catheters (20 Ga.; Arrow Int., Reading, PA) were placed
in the femoral artery and vein of the experimental leg
(right) and in the femoral artery of the nonexperimental
leg (left). Following 30 min of rest, subjects were posi-
tioned in a supine position where they received femoral
arterial infusion of: (1) ACh (25 and 100 lg min1 kg leg
per mass; Miochol-E, Bausch & Lomb Inc., Bridgewater,
NJ) and (2) SNP (4 lg min1 kg leg per mass; Nitro-
press, Hospira Inc., Lake Forest, IL). Each dose of ACh
and SNP was infused for 2.5 min and measurements
(blood flow, blood pressure and arterial and venous blood
samples [~2 mL]) were obtained after 2.0 min. Infusion
of SNP was performed 30 min after infusion of the last
dose of ACh was terminated. After an additional 60 min
of rest, subjects performed knee-extensor exercise at three
different intensities: 6 W, 12 W and 40% of the maximal
workload obtained in the incremental test (40% Wmax;
19  1 and 15  1 W: young and older). Each workload
was sustained for 5 min and measurements were obtained
after 3.5 min. Exercise performed at 6 and 12 W were
completed consecutively whereas 40% Wmax was per-
formed after 5 min of rest. Following exercise, subjects
received an oral dose of the PDE5 inhibitor sildenafil
(100 mg; Actavis, Hafnarfjordur, Iceland). One hour after
sildenafil intake, infusion of ACh and SNP and knee-ex-
tensor exercise were repeated in the same order as during
the control condition.
Measurements and calculations
Femoral arterial blood flow (FABF) was measured with
ultrasound Doppler (Vivid E9; GE Healthcare, Brondby,
Denmark) equipped with a linear probe operating at an
imaging frequency of 11 MHz and Doppler frequency of
5.0 MHz and as previously described (Nyberg et al.
2014).
Intra-arterial and intra-venous pressure was monitored
with transducers (Pressure Monitoring Set, Edwards Life-
sciences, Irvine, CA) positioned at the level of the cathe-
ters. Blood gases, hemoglobin, glucose, and lactate were
measured using an ABL800 FLEX analyzer (Radiometer,
Bronshoj, Denmark). Total cholesterol, low-density
lipoprotein (LDL-C), and high-density lipoprotein
(HDL-C) were analyzed using an automatic analyzer using
enzymatic kits (Cobas 8000, Roche, Hvidovre, Denmark),
HbA1c using HPLC and noradrenaline using ELISA
(Research ELISA, LDN, Nordhorn, Germany). Leg mass
was calculated from whole-body dual-energy x-ray absorp-
tiometry scanning (Prodigy; GE Healthcare), leg vascular
conductance (LVC) as FABF/(mean femoral arterial pres-
sure [FAP]  mean femoral venous pressure [FVP]), leg
O2 delivery as arterial O2 content 9 FABF, leg O2 uptake
as arteriovenous O2 difference 9 FABF, leg lactate release
as arteriovenous lactate difference 9 FABF, change in leg
lactate release as leg lactate release with sildenafil – leg lac-
tate release in the control setting, change in leg O2 delivery
as leg O2 delivery with sildenafil – leg O2 delivery in the
control setting, change in leg O2 uptake as leg O2 uptake
with sildenafil – leg O2 delivery in the control setting and
difference in leg O2 delivery – leg O2 uptake was calculated
by subtracting leg O2 uptake from leg O2 delivery.
Statistical analysis
Specific hypothesis testing during rest, infusion, and exer-
cise was performed with two-way repeated-measures anal-
yses of variance. After a significant F test, pairwise
differences were identified using a Student-Newman–
Keuls post hoc test. Differences between young and older
subjects at specific time points were assessed with
unpaired t-tests and changes within each group with one-
sample t-tests. Pearson correlation analysis was used to
determine relations of interest. The number of subjects
was selected on basis of detecting ~10% differences in
blood flow, O2 delivery, and O2 uptake within each group
with intake of sildenafil, as these were the main outcomes
of the study. Statistical significance was set at a priori at
0.05 and data are presented as means  SEM.
Results
Arterial ACh infusion
Sildenafil increased FABF at rest in both young (P < 0.05)
and older (P < 0.05) subjects (Fig. 1). In the older subjects,
FABF was lower (P < 0.05) than that of the young subjects
during both infusion doses without and with sildenafil.
FAP was lower with sildenafil at rest (P < 0.05) and during
infusion of the low (P < 0.05) and high dose (P < 0.05) of
ACh. In the older subjects, FAP was higher (P < 0.05) at
rest and during infusion of the low dose of ACh, but this
difference was abolished with sildenafil. At rest and during
each infusion, FAP decreased to a larger extent (P < 0.05)
in the older (14  2, 13  2 and 15  2 mmHg; rest, low
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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dose and high dose) compared to the young (7  2, 5  2
and 5  2 mmHg) subjects with sildenafil. At rest, femoral
venous plasma noradrenaline increased to a similar extent
in the young (1.3  0.2 nmol L1) and older
(1.6  0.7 nmol L1) subjects with sildenafil. Following
intake of sildenafil, LVC increased (P < 0.05) at rest and
during the highest dose of ACh in both groups whereas it
only increased (P < 0.05) in the older subjects during the
low dose of ACh. LVC was lower (P < 0.05) in the older
subjects during both infusion doses with and without silde-
Figure 1. Femoral arterial blood flow (A), mean femoral arterial
blood pressure (B), and leg vascular conductance (C) in young and
older subjects at rest and during femoral arterial ACh infusion
without (CON) and with sildenafil. Significant difference from CON
within same condition: *P < 0.05; significant difference from young
within same condition: #P < 0.05.
Figure 2. Femoral arterial blood flow (A), mean femoral arterial
blood pressure (B), and leg vascular conductance (C) in young and
older subjects at rest and during femoral arterial sodium
nitroprusside (SNP) infusion without (CON) and with sildenafil.
Significant difference from CON within same condition: *P < 0.05;
significant difference from young within same condition: #P < 0.05.
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nafil. Blood variables, heart rate and FVP are presented in
Table S1A and B.
Arterial SNP infusion
Sildenafil increased (P < 0.05) FABF during SNP infusion
in the young subjects whereas no significant difference
was detected in the older group (Fig. 2). FAP was lower
(P < 0.05) with sildenafil during infusion of SNP in
young and older subjects, resulting in higher (P < 0.05)
LVC in both groups during infusion of SNP. The decrease
in FAP with SNP was more pronounced (P < 0.05) in the
older (14  2 mmHg) compared to the young (4  2
mmHg). A difference in the magnitude of change in
Figure 3. Femoral arterial blood flow (A), leg O2 delivery (B), mean femoral arterial blood pressure (C), leg arteriovenous O2 difference (D), leg
vascular conductance (E), and leg O2 uptake (F) in young and older subjects during knee-extensor exercise performed at 6 W, 12 W, and 40%Wmax
(19  1 and 15  1 W: young and older) without (CON) and with sildenafil. Significant difference from CON within same condition: *P < 0.05.
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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FABF (0.17  0.12 and 0.15  0.14 L min1, young and
older subjects) and LVC (4.1  1.9 and 7.3  1.8
mL min1 mmHg1) with SNP without and with silde-
nafil was not detected between the young and older
groups. Blood variables, heart rate, and FVP are presented
in Table S2A and B.
Knee-extensor exercise
Sildenafil increased (P < 0.05) FABF at all exercise inten-
sities in the older subjects (Fig. 3). Leg O2 uptake
increased (P < 0.05) at all intensities in the older group
with sildenafil. In the young group, FAP was lower
(P < 0.05) with sildenafil at 6 and 12 W and lower
(P < 0.05) at all exercise intensities in the older group.
LVC with sildenafil was unaltered in the young and
increased (P < 0.05) at all exercise intensities in the older
subjects.
When expressed as change in response to sildenafil
intake, leg O2 delivery (6.3  2.4, 6.0  1.7 and
9.3  4.0%; 6, 12 and 40% Wmax), and leg O2 uptake
(11.6  3.9, 10.4  2.8 and 12.8  4.8%) increased
(P < 0.05) at all exercise intensities in the older group
(Fig. 4). The change in leg O2 delivery with sildenafil
Figure 5. Difference between leg O2 delivery and leg O2 uptake
(A) and association between change in leg O2 uptake and lactate
release with sildenafil (B) in young and older subjects performing
knee-extensor exercise at 6 W, 12 W, and 40% Wmax (19  1 and
15  1 W: young and older). Significant difference from young
within same condition: #P < 0.05.
Figure 4. Change in leg O2 delivery with sildenafil (A), change
in leg O2 uptake with sildenafil (B) and the association between
the change in leg O2 delivery and the change in leg O2 delivery
with sildenafil (C) in young and older subjects performing knee-
extensor exercise at 6 W, 12 W, and 40% Wmax (19  1 and
15  1 W: young and older). Significant difference: *P < 0.05;
significant difference from young within same condition:
#P < 0.05.
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correlated with the change in leg O2 uptake in the older
(r2 = 0.843, P < 0.001) but not young (r2 = 0.024) sub-
jects. The difference between leg O2 delivery and O2 uptake
was greater (P < 0.05) in the young compared to the older
subjects at all exercise intensities in the control condition
and a negative association between the change in leg O2
uptake and leg lactate release was detected in the older
(r2 = 0.445, P = 0.001) and young (r2 = 0.281, P = 0.004)
subjects (Fig. 5). The change in leg O2 uptake for a given
change in power output during knee-extensor exercise (cal-
culated as the slope of the linear regression of leg O2 uptake
on power output for each subject; Fig. 6A) was lower
(P < 0.05) in older compared to young subjects in the con-
trol condition (Fig. 6B). No significant difference was
detected in the change in power output for a given change
in leg O2 uptake with sildenafil in either group. Blood vari-
ables, heart rate, and FVP are presented in Table 2.
There were no associations between the changes in
leg O2 delivery with sildenafil and age, systolic blood
pressure, FAP, HbA1c, total cholesterol, and LDL
cholesterol.
Discussion
The findings from the current study demonstrate that
potentiation of cGMP signaling by inhibition of PDE5
activity increases blood flow, O2 delivery, and O2 uptake
in the exercising lower limb of older but not young
human subjects during submaximal exercise engaging a
small muscle mass. This effect of cGMP potentiation sug-
gests an insufficient blood flow and O2 delivery to the
contracting skeletal muscle of aged individuals and that a
reduced cGMP level is a novel mechanism by which
skeletal muscle blood flow and O2 delivery are impaired
with advancing age in humans.
Blood flow to contracting skeletal muscle is closely reg-
ulated as a function of O2 bound to hemoglobin and
arterial O2 content so that O2 delivery matches the O2
demand (Saltin et al. 1998; Roach et al. 1999; Gonzalez-
Alonso et al. 2001). Aging is associated with a decline in
hemoglobin levels and arterial O2 content (Ershler et al.
2005). Therefore, a lowered (Proctor et al. 1998; Lawren-
son et al. 2003; Poole et al. 2003; Kirby et al. 2012;
Nyberg et al. 2012) or unaltered (Beere et al. 1999; Proc-
tor et al. 2003) blood flow to contracting skeletal muscle
in aged individuals could result in an insufficient O2
delivery to meet the O2 demand of the contracting skele-
tal muscles. In the current study, hemoglobin levels, arte-
rial O2 content, and the difference between O2 delivery
and O2 uptake were lower in the older group, suggesting
that O2 delivery could limit oxidative metabolism. We
did not detect a difference in O2 uptake during submaxi-
mal exercise between the young and the older group in
the control setting and although this would indicate that
O2 delivery was sufficient to meet the O2 demand, age-re-
lated differences in mechanical efficiency with the possi-
bility of anaerobic energy contribution needs to be taken
into account. Accordingly, impaired mitochondrial and
contractile efficiency has been documented in the human
quadriceps muscle of aged subjects (Conley et al. 2013;
Layec et al. 2015), suggesting that the metabolic demand
for the same absolute workload was higher in the older
group in the current study. The change in power output
for a given change in leg O2 uptake during knee-extensor
exercise was also found to be lower in the older group
(Fig. 6A and B), which is in support of a lower mechani-
cal efficiency. Hence, the increase in O2 uptake with silde-
nafil in the older subjects is likely to reflect that oxidative
metabolism in the control setting was compromised by
insufficient O2 delivery. Notably, the lower difference
between O2 delivery and O2 uptake in the older group
was unaltered with sildenafil. This finding is explained by
Figure 6. Association between workload and leg O2 uptake (A)
and change in power output for a given change in leg O2 uptake
(B) in young and older subjects performing knee knee-extensor
exercise at 6 W, 12 W, and 40% Wmax (19  1 and 15  1 W:
young and older). Significant difference from young within same
condition: #P < 0.05.
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Table 2. Blood variables during knee-extensor exercise.
Blood variable
6 W 12 W 40% Wmax
CON SILD CON SILD CON SILD
Young
PO2 (mmHg)
a 107  3 102  2* 103  3 102  2 104  2 103  2
v 26  1 25  1 25  1 25  1 25  1 25  1
Hemoglobin (g dL1)
a 14.6  0.2 14.5  0.2 14.7  0.2 14.7  0.2 14.7  0.3 14.7  0.2
v 14.4  0.3 14.2  0.3 14.4  0.2 14.1  0.2 14.2  0.3 14.2  0.3
O2 saturation (%)
a 98.2  0.1 98.0  0.1 98.1  0.1 97.9  0.1 98.1  0.1 98.0  0.1
v 40.7  2.3 39.8  1.2 38.9  2.1 40.1  1.4 38.2  1.8 38.5  1.5
O2 content (mL L
1)
a 195  2 194  3 196  3 195  3 196  3 196  3
v 80  6 77  3 76  5 77  3 74  5 74  3
Lactate (mmol L1)
a 1.5  0.3 1.2  0.2 1.8  0.4 1.3  0.3 2.1  0.4 1.6  0.4
v 2.2  0.5 1.5  0.3* 2.4  0.6 1.5  0.4* 2.6  0.6 2.1  0.6
Lactate release (mmol min1)
1.1  0.3 0.5  0.3* 1.2  0.6 0.4  0.4* 1.2  0.7 1.1  0.6
pH
a 7.394  0.007 7.393  0.005 7.384  0.006 7.396  0.004 7.380  0.005 7.394  0.007*
v 7.304  0.011 7.327  0.005* 7.296  0.012 7.320  0.010* 7.289  0.011 7.306  0.012*
Heart rate (beats per minute)
89  7 87  5 94  8 94  6 99  6 100  6
FVP (mmHg)
18.4  0.9 17.4  1.2 17.6  1.0 17.3  1.0 17.5  0.8 18.0  1.0
Older
PO2 (mmHg)
a 85  4† 76  3*† 83  3† 77  3† 80  4† 78  4†
v 25  1 23  0** 24  1 22  1 23  1 22  1
Hemoglobin (g dL1)
a 13.6  0.3† 13.3  0.4*† 13.7  0.4† 13.5  0.3† 13.5  0.3† 13.3  0.4†
v 13.4  0.3† 13.1  0.4† 13.3  0.4† 13.0  0.3† 13.6  0.3 13.3  0.3
O2 saturation (%)
a 96.1  0.3† 94.8  0.4*† 95.9  0.3† 94.9  0.5*† 95.5  0.5† 95.1  0.6†
v 37.0  1.8 33.1  1.5*† 33.3  1.7† 30.1  2.2*† 31.2  2.2† 28.5  2.0†
O2 content (mL L
1)
a 177  4† 172  5*† 178  5† 174  6*† 176  4† 172  5*†
v 67  3† 59  3*† 60  3*† 53  4† 57  4† 51  4*†
Lactate (mmol L1)
a 1.2  0.2 1.0  0.1 1.2  0.1 1.1  0.1 1.2  0.1 1.1  0.1
v 1.5  0.2 1.2  0.1 1.4  0.2 1.2  0.1 1.6  0.2 1.4  0.2
Lactate release (mmol min1)
0.6  0.1 0.4  0.2 0.5  0.2 0.3  0.2 0.7  0.3 0.7  0.3
pH
a 7.413  0.006† 7.421  0.005† 7.412  0.005† 7.424  0.006† 7.410  0.008† 7.431  0.005*†
v 7.336  0.007† 7.350  0.004* 7.337  0.005† 7.342  0.006 7.333  0.006† 7.339  0.006†
Heart rate (beats per minute)
74  5 74  5 78  5 79  6 82  6 81  6
FVP (mmHg)
19.7  1.6 19.0  1.8 19.7  1.8 19.8  1.9 20.2  1.8 19.7  1.9
a, femoral arterial; v, femoral venous.
*Significant difference from CON within same condition (P < 0.05).
†Significant difference from young within same condition (P < 0.05).
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the close association between the increase in O2 delivery
and O2 uptake and is in agreement with an insufficient O2
delivery in the control setting.
An insufficient O2 delivery to meet the oxidative demand
in the older subjects would entail that anaerobic metabo-
lism compensated for the lower aerobic metabolism. With
regard to quantification of anaerobic metabolism, although
lactate is formed and utilized continuously under fully aer-
obic conditions (Brooks 2009). Lactate leaving the exercis-
ing limb is still descriptive of anaerobic glycolysis in
skeletal muscle (Juel and Halestrap 1999). As no difference
in leg lactate release in the control condition was detected
between the two groups, it may be that the intracellular
level of lactate in the muscle of the older subjects was
higher as the capacity to release lactate from the active
muscle fibers may have been reduced. In line with this sug-
gestion, the two important lactate transporters MCT1 and
MCT4 have been shown to be downregulated in aging
skeletal muscle (Masuda et al. 2009). Furthermore, in a
previous study on older lifelong physically sedentary sub-
jects, lactate release from the exercising leg was found to be
similar to that of young adults despite a lower leg O2
uptake in the older group (Nyberg et al. 2012), indicating
that lactate release was reduced as anaerobic metabolism
would be expected to compensate for the lower oxidative
metabolism. Importantly, the change in leg O2 uptake with
sildenafil in the current study was negatively correlated
with the change in lactate release, indicating that the
increase in oxidative metabolism reduced anaerobic meta-
bolism.
An insufficient O2 delivery to meet the metabolic
demand of the contracting skeletal muscles in aging was
also supported by a close association (r2 = 0.843) between
the change in O2 delivery and O2 uptake with sildenafil.
Alternatively, the increase in O2 delivery with sildenafil
could be a result of an increased metabolic demand due
to reduced mitochondrial efficiency, however, sildenafil
has been shown not to affect oxidative phosphorylation
in isolated mitochondria (Fernandes et al. 2008) and lac-
tate levels and the change in power output for a given
change in leg O2 uptake did not change with sildenafil.
In the current study, blood flow, O2 delivery, and O2
uptake was found to increase by ~6–12% during exercise
in the older subjects with sildenafil. Previous studies have
shown reductions of ~10–20% in blood flow and O2
uptake (Proctor et al. 1998; Lawrenson et al. 2003; Poole
et al. 2003; Kirby et al. 2012; Nyberg et al. 2012) in aged
individuals compared to young, indicating that the
increase in these variables in the current study are of
physiological relevance. It would, therefore, be of interest
in future studies to examine the extent to which PDE5
inhibition can improve the functional capacity of older
subjects. In this context, it may be that during exercise
involving a large muscle mass, arterial blood pressure fol-
lowing sildenafil intake could compromise perfusion of
the contracting muscles, thereby negating the effect
observed during small muscle mass exercise.
Despite many efforts to determine the effects of aging
on exercise hyperemia, a fundamental question regarding
the mechanisms by which blood flow is altered remains
unanswered. The cyclic nucleotide cGMP is considered
one of the main second messengers that mediate vasodila-
tion (Morgado et al. 2012). Acute potentiation of cGMP
signaling via inhibition of PDE5 has been shown to
increase blood flow following forearm contractions in
hypertensive subjects (Attina et al. 2008) and skeletal
muscle oxygenation during exercise in patients with
atherosclerotic disease (Roseguini et al. 2014) and an
altered cGMP signaling could be one mechanism by
which blood flow regulation during exercise is impaired
in aging. In the present study, potentiation of cGMP sig-
naling by inhibition of PDE5 increased LVC and blood
flow during exercise in the older but not young group.
This effect of PDE5 inhibition specifically in the older
group could reflect that aged individuals have generally
higher activity of PDE5 and/or lower cGMP formation in
contracting skeletal muscle. Although it is difficult to dif-
ferentiate between these mechanisms based on an integra-
tive response to PDE5 inhibition, the finding that
sildenafil increased LVC to a similar extent in response to
infusion of an NO donor is indicative of a similar activity
of PDE5 in the young and older subjects. Hence, this
finding on the vascular response to an NO donor is in
line with a reduced cGMP formation in contracting skele-
tal muscle of older individuals.
The vasoactive substance NO plays a key role in the
regulation of systemic blood pressure (Rees et al. 1989).
Thus, the observation that sildenafil was found to induce
a more marked reduction in blood pressure in the older
subjects is in agreement with a reduced cGMP availability
in the older subjects. This effect of PDE5 inhibition on
blood pressure in the older group could be related to a
higher initial blood pressure and hence less pronounced
baroreceptor buffering in these subjects. However, a dif-
ference in the change in venous noradrenaline, which has
been shown to correlate closely with acute changes in
skeletal muscle sympathetic nervous activity (Grassi et al.
2008), was not found between the two groups following
intake of sildenafil. This observation is also in line with a
previous study demonstrating that the reduction in blood
pressure with sildenafil was more related to age than
blood pressure per se (Vardi et al. 2002).
It has been shown that aging is associated with a
reduced vascular response to infusion of the endothe-
lium-dependent vasodilator ACh (Taddei et al. 2001;
Mortensen et al. 2012) as a consequence of a lower NO
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
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bioavailability (Taddei et al. 2001). In the current study,
the vasodilator response to ACh was accordingly found to
be lower in the older than the young group in the control
setting. Although speculative, this could indicate that a
diminished endothelial NO bioavailability was one factor
contributing to lower cGMP levels during exercise. Nota-
bly, NO does not appear to be obligatory for exercise
hyperemia during lower limb exercise in young subjects
(Radegran and Saltin 1999) and a lower NO bioavailabil-
ity would, therefore, entail an altered role of the NO sys-
tem and/or that redundant systems that would normally
compensate for a reduced NO formation are also affected
by aging (Mortensen et al. 2007; Schrage et al. 2007).
Many biological events associated with advancing age
are due to complex and integrated alterations in physio-
logical systems that are influenced by genetic and life-style
factors. One important lifestyle factor is the level of physi-
cal activity as evidenced by studies on enforced inactivity
such as bed rest that initiates an “accelerated aging” pro-
cess (Saltin et al. 1968; McGuire et al. 2001), and it has
been argued that being physically active is the default
requirement for maintaining health and physiological
function throughout the life span (Lazarus and Harridge
2010). Therefore, we chose to include subjects that were
characterized by a moderate level of physical activity in
order to limit the potential adverse effects of skeletal
muscle disuse in an attempt to elucidate the effects of pri-
mary aging. Hence, the finding that PDE5 inhibition
increased blood flow and O2 uptake in these recreation-
ally active subjects indicates that groups characterized by
pronounced impaired endothelial function such as hyper-
tension (Taddei et al. 1997; Attina et al. 2008), diabetes
(Schalkwijk and Stehouwer 2005) and hypercholes-
terolemia (Creager et al. 1990) may benefit even more
from potentiation of cGMP signaling.
Summary
The current study shows that potentiation of cGMP signal-
ing increases blood flow, O2 delivery, and oxidative meta-
bolism in the exercising lower limb of older but not young
healthy human subjects during submaximal exercise engag-
ing only a small muscle mass. This finding suggest that a
reduced O2 delivery to contracting skeletal muscle of older
individuals have metabolic consequences that, at least in
part, may explain the impairment in physical capacity asso-
ciated with aging and that reduced levels of cGMP is one
mechanism underlying the insufficient O2 delivery.
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